Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Miami, Miller School of Medicine, Miami, FL.
Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Miami, Miller School of Medicine, Miami, FL.
Surgery. 2019 Sep;166(3):375-379. doi: 10.1016/j.surg.2019.04.022. Epub 2019 Jun 10.
In response to the growing opioid crisis, Florida recently implemented a law restricting the duration of opioid prescriptions for acute pain. Little is known about the impact of such legislation on opioid prescription practices at the time of discharge after surgery. The objective of this study was to determine whether Florida's new legislation changed opioid prescription practices for analgesia after surgery.
Adults 18 years of age and older undergoing cholecystectomy, appendectomy, hernia repair, hysterectomy, mastectomy, or lymph node dissection were included in this retrospective cohort study at a large public university-affiliated hospital. We analyzed opioid prescriptions on discharge after these common outpatient surgical procedures between June 1, 2017, and December 31, 2018. Florida House Bill 21 was passed on March 2, 2018, and subsequent implementation of this law took place on July 1, 2018. The law restricts the duration of opioid prescriptions for acute pain to 3 days, which can be extended up to a maximum of 7 days with additional documentation. The outcomes studied included the following: the proportion of patients receiving opioid prescriptions on discharge, total opioid dose prescribed, daily opioid dose prescribed, and the proportion of patients receiving more than a 3-day supply of opioids. We colledted data on emergency department cumulative visits within 7 and 30 days after discharge. Drug doses were converted to morphine milligram equivalents and calculated for each selected procedure.
A total of 1,467 surgical encounters were included. The cohort was predominantly female (963 [65.6%]) with a mean (SD) age of 49.6 (14.4) years. At 6 months after implementation of HB 21, the proportion of patients receiving opioid prescriptions decreased by 21% (95% CI 16.8% to 25.3%, P < .001), mean total opioid dose prescribed decreased by 64.2 morphine milligram equivalents (95% CI 54.7 to 73.7, P < .001) from a baseline mean (SD) of 172.5 (78.9) morphine milligram equivalents. The mean daily opioid dose prescribed increased by 3.5 morphine milligram equivalents (95% CI 1.8 to 5.1, P < .001) from a baseline mean (SD) of 30.5 (9.4) morphine milligram equivalents. The proportion of patients receiving opioid prescriptions for longer than a 3-day supply decreased by 68% (95% CI 63.4% to 72.7%, P < .001). We observed no change in the number of postoperative emergency department visits before and after implementation of the law.
Opioid prescriptions for patients undergoing common outpatient surgical procedures at a large public university-affiliated hospital in Florida were substantially reduced within 6 months after implementation of state legislation limiting the duration of opioid prescriptions. This reduction was not associated with an increase in the number of postoperative emergency department visits. The legislation should significantly decrease the amount of unused opioid pills potentially available for diversion and abuse. Secondary effects from the enactment of this law remain to be evaluated.
为应对日益严重的阿片类药物危机,佛罗里达州最近实施了一项法律,限制急性疼痛的阿片类药物处方期限。在手术后出院时,这种立法对阿片类药物处方实践的影响知之甚少。本研究的目的是确定佛罗里达州的新立法是否改变了手术后的镇痛阿片类药物处方实践。
本回顾性队列研究纳入了在一家大型公立大学附属医院接受胆囊切除术、阑尾切除术、疝修补术、子宫切除术、乳房切除术或淋巴结清扫术的 18 岁及以上成年人。我们分析了 2017 年 6 月 1 日至 2018 年 12 月 31 日期间这些常见门诊手术出院后的阿片类药物处方。2018 年 3 月 2 日通过了佛罗里达州众议院法案 21 号,该法律于 2018 年 7 月 1 日生效。该法律将急性疼痛的阿片类药物处方期限限制为 3 天,但如果有额外的文件证明,可以延长至最长 7 天。研究的结果包括:出院时接受阿片类药物处方的患者比例、开具的总阿片类药物剂量、开具的每日阿片类药物剂量以及接受超过 3 天供应量阿片类药物的患者比例。我们收集了出院后 7 天和 30 天内急诊就诊的累计数据。将药物剂量转换为吗啡毫克当量,并为每个选定的程序进行计算。
共纳入 1467 例手术。队列主要为女性(963 [65.6%]),平均(SD)年龄为 49.6(14.4)岁。在 HB 21 实施 6 个月后,接受阿片类药物处方的患者比例下降了 21%(95%CI 16.8%至 25.3%,P<0.001),开具的总阿片类药物剂量从基线平均(SD)的 172.5(78.9)吗啡毫克当量减少了 64.2 吗啡毫克当量(95%CI 54.7 至 73.7,P<0.001)。开具的每日阿片类药物剂量增加了 3.5 吗啡毫克当量(95%CI 1.8 至 5.1,P<0.001),从基线平均(SD)的 30.5(9.4)吗啡毫克当量。接受超过 3 天供应量阿片类药物处方的患者比例下降了 68%(95%CI 63.4%至 72.7%,P<0.001)。我们在法律实施前后没有观察到术后急诊就诊次数的变化。
在佛罗里达州一家大型公立大学附属医院接受常见门诊手术的患者的阿片类药物处方在该州限制阿片类药物处方期限的立法实施后 6 个月内大幅减少。这种减少与术后急诊就诊次数的增加无关。该立法应显著减少潜在可用于转移和滥用的未使用阿片类药物药丸数量。该法律颁布的次要影响仍有待评估。